Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy

Published:2016-04 Issue: Volume:228 Page:107-119
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Li Yuanke^ORCID,Wu Yuanyuan,Huang Leaf,Miao Lei,Zhou Jianping,Satterlee Andrew Benson,Yao Jing

Funder

Jiangsu Natural Science Foundation of China

12th of Six Talent Peak Foundation of Jiangsu Province

National Natural Science Foundation of China

Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University

Fundamental Research Funds for the Central Universities

Qing Lan Project

Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference62 articles.

1. Role of angiogenesis in tumor growth and metastasis;Folkman;Semin. Oncol.,2002

2. New developments in angiogenesis: a major mechanism for tumor growth and target for therapy;Jones;Cancer J. Sci. Am.,1998

3. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model;Debergh;Br. J. Cancer,2010

4. The generation of iPS cells using non-viral magnetic nanoparticle based transfection;Lee;Biomaterials,2011

5. Proteoglycans as modulators of growth factor activities;Ruoslahti;Cell,1991

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Terpenoid-Based Sustainable Thermoplastics, Cross-Linked Polymers, and Supramolecular Materials;Polymer Reviews;2023-05-09

2. Terpenoid-based supramolecular materials: fabrications, performances, applications;Supramolecular Chemistry;2023-02

3. Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment;Theranostics;2022

4. Development of carrier-free nanodrugs based on low molecular weight heparin–doxorubicin conjugate assembly with smart pH-triggered drug release characteristics for combinatorial antitumor therapy;New Journal of Chemistry;2022

5. Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy;Journal of Controlled Release;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3